Bichen Pharmaceutical
About:
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
Website: http://www.abmtx.com
Top Investors: Highlight Capital, Delta Capital, Baidu Ventures, Kaitai Capital, Pan-Lin Capital
Description:
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
Total Funding Amount:
$50M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2015-01-01
Contact Email:
info(AT)abmtx.com
Founders:
Number of Employees:
51-100
Last Funding Date:
2022-01-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai